Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advocating for patients with urinary retention and lower urinary tract obstruction regardless of etiology "Establishing maximal wait times for urologic surgery in Canada in 2024" (Can Urol Assoc J 2024;18:376-8).

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025
Same author

Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial.

BJUI compass·2024
Same author

Editorial Commentary.

Urology practice·2023
Same author

Social Media and Online Communication: Clinical Urology Practice in the 21st Century.

Urology practice·2023
Same author

Editorial Commentary.

Urology practice·2023
Same author

Editorial Commentary.

Urology practice·2023

Related Experiment Video

Updated: Mar 19, 2026

Fixation of Ultrasound Transducers for Spinal Cord Neuromodulation in Mice
03:26

Fixation of Ultrasound Transducers for Spinal Cord Neuromodulation in Mice

Published on: August 1, 2025

892

Sacral Neuromodulation in Urological Practice.

Daniel Liberman1, Michael J Ehlert1, Steven W Siegel1

  • 1Metro Urology, Woodbury, MN.

Urology
|June 15, 2016
PubMed
Summary
This summary is machine-generated.

Sacral neuromodulation (SNM) offers a minimally invasive solution for improving bladder and bowel function. Future advancements aim to enhance SNM

More Related Videos

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

1.4K
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

Fixation of Ultrasound Transducers for Spinal Cord Neuromodulation in Mice
03:26

Fixation of Ultrasound Transducers for Spinal Cord Neuromodulation in Mice

Published on: August 1, 2025

892
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

1.4K
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
03:26

Detrusor Underactivity Model in Rats by Conus Medullaris Transection

Published on: August 28, 2020

2.4K

Area of Science:

  • Urology
  • Neurology
  • Medical Devices

Background:

  • Sacral neuromodulation (SNM) is an established therapy for functional voiding and elimination disorders.
  • Existing evidence supports SNM for FDA-approved indications and international applications.

Purpose of the Study:

  • To provide a historical overview of sacral neuromodulation (SNM).
  • To review the current evidence for SNM in approved and emerging applications.
  • To discuss future directions for optimizing SNM therapy.

Main Methods:

  • Historical perspective and evidence review of sacral neuromodulation.
  • Analysis of SNM for Food and Drug Administration-approved pathologies.
  • Exploration of international SNM applications and disease targets.

Main Results:

  • SNM is a restorative treatment for voiding and elimination dysfunctions.
  • Optimal lead placement is crucial for effective and durable SNM outcomes.
  • SNM is utilized internationally for various conditions beyond FDA approvals.

Conclusions:

  • Sacral neuromodulation is a valuable therapeutic option for multiple functional disorders.
  • Future SNM development focuses on improved devices, software, programming, and nerve targets.
  • Continued research aims to maximize SNM benefits while minimizing risks and costs.